Walden Group Healthcare M&A Blog

Surmodics Acquires Ireland–based Vetex Medical

7/12/2021
Surmodics, Inc., a $107m maker of surface modification technologies for intravascular medical devices, has acquired Vetex Medical Ltd, an Ireland–based producer of venous clot removal products. Vetex developed ReVene, a thrombectomy catheter platform that is used to remove, in a single session, large, mixed-morphology blood clots commonly found...
Read More
Tecan Group Acquires Paramit for $1b

6/29/2021
Tecan Group Ltd, a $795m Switzerland-based global provider of laboratory instruments and solutions in life science research and clinical diagnostics, has acquired Paramit Corporation, a maker of electronics based medical devices and life science instruments. The deal accelerates Tecan's entry into medical devices and enhances Paramit's...
Read More
DENTSPLY SIRONA Inc. Acquires Propel Orthodontics for $131M

6/14/2021
DENTSPLY SIRONA (Nasdaq: XRAY), a $3.3b provider of dental technologies, equipment and consumables has acquired Propel Orthodontics, developer of the VPro, a vibratory orthodontic device that seats aligners in 5 minutes a day for at-home use. The VPro device is used with Propel’s Fastrack Mobile App that patients can use to track usage and...
Read More
Japan-based Olympus Corporation Acquires Israel-based Medi-Tate

6/2/2021
Adds an in-office treatment for benign prostatic hyperplasia (BPH) treatment to Olympus’ leading urological devices portfolio. Medi-Tate's “iTind” has received FDA de Novo authorization and a European CE mark. Since November 2018, Olympus secured distribution rights to iTind via an initial investment. The incidence of BPH is one of...
Read More
GE Healthcare Buys Molecular Imaging Agent Producer Zionexa

5/17/2021
General Electric (NYSE: GE), through its $18b healthcare business GE Healthcare, has acquired France-based Zionexa, the developer of a positron emission tomography (PET) imaging agent, Cerianna, used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions in recurrent or metastatic breast cancer care. Cerianna was...
Read More